Leiden-based ProQR Therapeutics, a biotech company specializing in RNA therapies, has secured €7.7 million ($8.1 million USD) in additional funding from the Rett Syndrome Research Trust (RSRT).
Copyright © 2023. Founders Today. All rights reserved
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?